Nicolas Pauillac
Stock Analyst at Kepler Capital
(4.66)
# 849
Out of 5,005 analysts
367
Total ratings
52.6%
Success rate
17.3%
Average return
Main Sectors:
Stocks Rated by Nicolas Pauillac
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: GSK GSK plc | Upgraded: Buy | 1,500p → 2,516p | 1,888p | +33.26% | 2 | May 26, 2026 | |
| SWX: CMHC Cosmo N.V. | Reiterated: Buy | CHF 130.00 | CHF 54.00 | +140.74% | 35 | May 11, 2026 | |
| SWX: SDZ Sandoz Group AG | Reiterated: Buy | CHF 80.00 | CHF 71.92 | +11.23% | 29 | May 11, 2026 | |
| EPA: CVX Carvolix SA | Reiterated: Buy | €5.00 | €5.52 | -9.42% | 30 | May 4, 2026 | |
| EPA: OSE OSE Immunotherapeutics SA | Reiterated: Buy | €8.20 | €2.37 | +246.28% | 40 | Apr 30, 2026 | |
| SWX: IDIA Idorsia Ltd | Reiterated: Buy | CHF 4.50 | CHF 4.38 | +2.74% | 1 | Apr 28, 2026 | |
| SWX: BION BB Biotech AG | Reiterated: Buy | CHF 66.00 → CHF 73.00 | CHF 51.40 | +42.02% | 15 | Apr 24, 2026 | |
| EPA: SAN Sanofi | Reiterated: Hold | €85.00 | €72.00 | +18.06% | 16 | Apr 23, 2026 | |
| ETR: FYB Formycon AG | Reiterated: Buy | €33.00 | €18.94 | +74.23% | 51 | Apr 22, 2026 | |
| ETR: EUZ Eckert & Ziegler SE | Reiterated: Buy | €20.30 | €12.55 | +61.75% | 34 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €36.60 | €23.86 | +53.39% | 33 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €5.00 | €2.79 | +79.21% | 8 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €15.00 | €7.05 | n/a | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €390.00 | €307.50 | n/a | 19 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | €0.80 → €0.64 | €0.05 | n/a | 21 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $90 → $47 | $29.84 | n/a | 2 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €79.00 → €41.00 | €25.98 | n/a | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $390 → $427 | $972.25 | n/a | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 57.00 | CHF 68.30 | n/a | 10 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €16.00 | €1.14 | n/a | 1 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €7.50 → €9.00 | €2.77 | n/a | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €0.60 → €0.40 | €0.59 | n/a | 4 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €2.70 | €0.33 | n/a | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €12.00 | €2.63 | n/a | 1 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €16.00 | €83.85 | n/a | 1 | Dec 21, 2022 |
GSK plc
May 26, 2026
Upgraded: Buy
Price Target: 1,500p → 2,516p
Current: 1,888p
Upside: +33.26%
Cosmo N.V.
May 11, 2026
Reiterated: Buy
Price Target: CHF 130.00
Current: CHF 54.00
Upside: +140.74%
Sandoz Group AG
May 11, 2026
Reiterated: Buy
Price Target: CHF 80.00
Current: CHF 71.92
Upside: +11.23%
Carvolix SA
May 4, 2026
Reiterated: Buy
Price Target: €5.00
Current: €5.52
Upside: -9.42%
OSE Immunotherapeutics SA
Apr 30, 2026
Reiterated: Buy
Price Target: €8.20
Current: €2.37
Upside: +246.28%
Idorsia Ltd
Apr 28, 2026
Reiterated: Buy
Price Target: CHF 4.50
Current: CHF 4.38
Upside: +2.74%
BB Biotech AG
Apr 24, 2026
Reiterated: Buy
Price Target: CHF 66.00 → CHF 73.00
Current: CHF 51.40
Upside: +42.02%
Sanofi
Apr 23, 2026
Reiterated: Hold
Price Target: €85.00
Current: €72.00
Upside: +18.06%
Formycon AG
Apr 22, 2026
Reiterated: Buy
Price Target: €33.00
Current: €18.94
Upside: +74.23%
Eckert & Ziegler SE
Apr 1, 2026
Reiterated: Buy
Price Target: €20.30
Current: €12.55
Upside: +61.75%
Mar 6, 2026
Reiterated: Buy
Price Target: €36.60
Current: €23.86
Upside: +53.39%
Feb 25, 2026
Reiterated: Buy
Price Target: €5.00
Current: €2.79
Upside: +79.21%
Sep 25, 2025
Reiterated: Hold
Price Target: €15.00
Current: €7.05
Upside: n/a
Jul 17, 2025
Reiterated: Hold
Price Target: €390.00
Current: €307.50
Upside: n/a
May 6, 2024
Reiterated: Sell
Price Target: €0.80 → €0.64
Current: €0.05
Upside: n/a
May 3, 2024
Reiterated: Hold
Price Target: $90 → $47
Current: $29.84
Upside: n/a
May 3, 2024
Reiterated: Hold
Price Target: €79.00 → €41.00
Current: €25.98
Upside: n/a
Feb 20, 2024
Reiterated: Hold
Price Target: $390 → $427
Current: $972.25
Upside: n/a
Nov 20, 2023
Reiterated: Buy
Price Target: CHF 57.00
Current: CHF 68.30
Upside: n/a
Sep 7, 2023
Reiterated: Buy
Price Target: €16.00
Current: €1.14
Upside: n/a
Aug 28, 2023
Upgraded: Buy
Price Target: €7.50 → €9.00
Current: €2.77
Upside: n/a
May 3, 2023
Reiterated: Buy
Price Target: €0.60 → €0.40
Current: €0.59
Upside: n/a
Apr 28, 2023
Reiterated: Buy
Price Target: €2.70
Current: €0.33
Upside: n/a
Dec 29, 2022
Reiterated: Buy
Price Target: €12.00
Current: €2.63
Upside: n/a
Dec 21, 2022
Reiterated: Buy
Price Target: €16.00
Current: €83.85
Upside: n/a